X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Looking forward to next week - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Jul 5, 2003

    Looking forward to next week

    This week was different as regards the movement of the indices. Oh no! They did not close the week in the negative, but yes, the gains were not as enthusing as were witnessed in the last two months. Both, the BSE Sensex and the NSE Nifty notched up gains of 1.1% over the week. This is relatively weak considering the 2%-3% weekly gains that were seen in the last two months. Another change observed on the bourses this week was the fact that unlike the previous weeks, wherein every fall in the indices, attracted investors, this week it was the other way round wherein at every rise, profit booking was seen. However, the bottomline is that the markets still managed to hold fort.

    Top 5 gainers over the week
    COMPANY Price on
    June 27 (Rs)
    Price on
    July 4 (Rs)
    % CHANGE 52-WEEK H/L (Rs)
    BSE-SENSEX 3,583 3,622 1.1% 3590 / 2828
    S&P CNX NIFTY 1,126 1,138 1.1% 1,127 / 920
    BURROUGH WEL 316 448 41.4% 490 / 185
    KINGFISHER PROPERTIES 22 29 30.5% 165 / 15
    CADILA HEALTHCARE 147 191 30.2% 205 / 110
    GERMAN REMEDIES 230 291 26.5% 307 / 194
    INDO RAMA SYN 31 39 25.6% 40 / 23

    Pharma stocks were in the limelight this week. As the pharma story seems be to unfolding, investors are realizing the growth potential of the industry. Optimism for the sector stems from the fact that India is likely to become an outsourcing hub soon. With increased competition from generics, MNC pharma majors will be looking at reducing their manufacturing costs in order to survive in the market and with India having USFDA approved manufacturing plants, our country would be an ideal outsourcing destination. Moreover, Indian pharma companies have shown their competitive strengths as they increasingly capture generics markets internationally.

    Top 5 losers over the week
    COMPANY Price on
    June 27 (Rs)
    Price on
    July 4 (Rs)
    % CHANGE 52-WEEK H/L (Rs)
    EXIDE INDUSTRIES 138 83 -40.1% 155 / 69
    CMC LTD. 479 429 -10.4% 627 / 361
    EIH ASSO. HOT 16 14 -9.3% 19 / 7
    INDIA CEMENTS 26 24 -9.1% 33 / 13
    HIND LEVER CHEM 203 186 -8.4% 208 / 142

    The fall in Exide Industries stock price is due to it going ex-bonus. The company had declared bonus shares in the ratio of 1:1, i.e. one bonus share for every share held and the allotment is due next week. Also, India Cements was amongst the top losers this week. This was primarily due to another year of disappointing results declared by the company. The company has reported a net loss of Rs 2 bn on the back of a significant 16% fall in topline. A drastic fall in realisations as well as a considerable rise in interest expenses has taken a toll on both the topline as well as the bottomline of the company in FY03.

    For detailed results: India Cements

    One sector, which seemed out of favour this week, was the software sector. The key reason for this could be the fact that investors are exercising caution before tech bellwether, Infosys, declares its results on July 10. The carnage seen on the bourses last time when the software major declared its 4QFY03 & FY03 results and gave a much below than expected guidance for the future, led to the de-rating of the entire software sector. Infosys alone lost 40% of its market capitalisation in just 2 trading sessions. However, this time around, investors seem a little bit more cautious.

    Key gainers across sectors over the week
    COMPANY Price on
    June 4 (Rs)
    Price on
    July 4 (Rs)
    % CHANGE
    BANKING
    ORIENTAL BANK 129 162 25.0%
    SBI 358 387 8.2%
    CEMENT
    ACC 148 169 13.8%
    GUJARAT AMBUJA 183 204 11.6%
    PHARMA
    DR.REDDY 929 1170 25.9%
    RANBAXY 676 834 23.4%
    ENERGY
    HPCL 317 358 12.8%
    BPCL 266 291 9.6%

    We are once again approaching the results season and next week will be very crucial for the Indian indices and moreso, for the software sector. All eyes are set on July 10, when Infosys declares its results, which will decide the fate of the sector, at least in the near-term. Any positive indication from the software major could set the momentum going again for the software sector. However, the strengthening rupee (currently at its 32-month high) continues to be a threat for the topline of software majors. As far as the overall market is concerned, investors can take solace from the fact that this time around, buying has not been restricted to a particular sector (see table 'Key movers across sectors'), but has rather been more broad-based. But, to sum it all up, apart from the volatility likely to be witnessed next week, investors should exercise caution for the near-term as the markets have had a huge run up in the last 2-3 months and hence, profit booking could be seen at higher levels. However, the long-term India Inc. growth story remains intact.

     

     

    Equitymaster requests your view! Post a comment on "Looking forward to next week". Click here!

      
     

    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    How To Read Your Mutual Fund Account Statement Correctly (Outside View)

    Aug 17, 2017

    PersonalFN simplifies the mutual fund account statement for you.

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process) (The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    Which Gods Will Bring Down the US Empire? (Vivek Kaul's Diary)

    Aug 17, 2017

    Mr Trump is in the White House and the gods are in their heavens; what's not to like?

    Will They Haul Off Trump's Statue, Too? (Vivek Kaul's Diary)

    Aug 16, 2017

    All across the country, the old gods become devils. New, gluten-free gods take their places...

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    S&P BSE SENSEX


    Aug 18, 2017 12:12 PM

    MARKET STATS